EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

NKp46 + ILC3s promote early neutrophil defense against Clostridioides difficile infection through GM-CSF secretion

José L Fachi, Sarah de Oliveira, Susan Gilfillan iD, Alina Ulezko Antonova, JinChao Hou, Marco A R Vinolo, Marco Colonna iD

Proceedings of the National Academy of Sciences · 05.11.2024 · 121 (45)

DOI: 10.1073/pnas.2416182121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 30.10.2024. Verfasst von José L Fachi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO 63110. Hauptthemen laut MEDLINE: Neutrophils, Clostridioides difficile, Natural Cytotoxicity Triggering Receptor 1, Clostridium Infections. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP), NIDDK NIH HHS, HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clostridioides difficile infection (CDI) is a common cause of antibiotic-associated colitis. C. difficile proliferates and produces toxins that damage the colonic epithelium, leading to symptoms ranging from mild diarrhea to severe pseudomembranous colitis. The host’s innate response to CDI occurs in two phases: an early phase in which neutrophils reduce the bacterial load and a late phase involving repair mechanisms to restore epithelial integrity. Group 3 innate lymphoid cells (ILC3s) are crucial in protecting the gut from CDI. Previous studies have shown that ILC3-derived IL-22 is essential in the late phase of CDI for epithelial repair and maintaining an intestinal microbiota that competes with C. difficile , preventing its expansion. Our study finds that ILC3s also protect during the early stages of CDI by sustaining neutrophils through GM-CSF. Less neutrophil production, accumulation, and activation was evident in ILC3-deficient mice than in wild-type (WT) mice, which led to exacerbated symptoms, impaired pathogen clearance, a compromised epithelial barrier, and increased mortality. The adoptive transfer of ILC3s into ILC3-deficient mice restored neutrophil responses and improved disease outcomes. Both in vitro and in vivo experiments revealed that GM-CSF production by ILC3s is crucial for neutrophil production and effective resistance during CDI. Using mice lacking NKp46 + ILC3s, we found that this subset significantly contributes to GM-CSF production in CDI. These findings highlight the critical role of the ILC3-neutrophil connection in early innate responses to CDI. Enhancing ILC3 production of GM-CSF could be a promising strategy for improving host defense against CDI and other enteric infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeutrophilsClostridioides difficileNatural Cytotoxicity Triggering Receptor 1Clostridium InfectionsGranulocyte-Macrophage Colony-Stimulating FactorLymphocytesImmunity, InnateAnimalsMiceMice, Inbred C57BLMice, KnockoutAntigens, LyInterleukin-22Intestinal Mucosa

Stichwörter der Autor:innen

Clostridioides difficileGM-CSFcolitisinnate lymphoid cellsneutrophils

Substanzen

Natural Cytotoxicity Triggering Receptor 1Granulocyte-Macrophage Colony-Stimulating FactorNcr1 protein, mouseAntigens, LyInterleukin-22

Autor:innen und Institutionen

  • Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO 63110.
  • Department of Genetics, Evolution, Microbiology, and Immunology, Institute of Biology, University of Campinas, Campinas, SP 13083-862, Brazil.
  • Department of Anesthesiology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou 310052, China.

ORCID-Profile: Susan Gilfillan, Marco Colonna

Förderung

  • Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
  • NIDDK NIH HHS
  • HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  • Pew Charitable Trusts (PCT)

Zitieren

APA

Fachi, J. L., Oliveira, S., Gilfillan, S., Antonova, A. U., Hou, J., Vinolo, M. A. R., & Colonna, M. (2024). NKp46 + ILC3s promote early neutrophil defense against Clostridioides difficile infection through GM-CSF secretion. Proceedings of the National Academy of Sciences, 121(45). https://doi.org/10.1073/pnas.2416182121

Vancouver

Fachi JL, Oliveira S, Gilfillan S, Antonova AU, Hou J, Vinolo MAR, et al. NKp46 + ILC3s promote early neutrophil defense against Clostridioides difficile infection through GM-CSF secretion. Proceedings of the National Academy of Sciences. 2024;121(45). doi:10.1073/pnas.2416182121

BibTeX
@article{Fachi2024,
  author = {Fachi, José L and Oliveira, Sarah de and Gilfillan, Susan and Antonova, Alina Ulezko and Hou, JinChao and Vinolo, Marco A R and Colonna, Marco},
  title = {NKp46 + ILC3s promote early neutrophil defense against Clostridioides difficile infection through GM-CSF secretion},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2024},
  volume = {121},
  number = {45},
  doi = {10.1073/pnas.2416182121}
}
Kostenlos starten →